Showing results (11-20 of 12,899) with videos related to
Sort By:
Pageof 1,290
Circulation|April 8, 1998
Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9BR A Kloner, T Shook, E M Antman, et al.American Heart Journal|January 7, 2003
Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 RegistryMaria Cecilia Bahit, Christopher P Cannon, Elliott M Antman, et al.Journal of the American College of Cardiology|September 1, 2004
Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarctionC Michael Gibson, Sabina A Murphy, Ajay J Kirtane, et al.The American Journal of Cardiology|February 17, 2001
Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study GroupC M Gibson, S A Murphy, S J Marble, et al.American Heart Journal|April 26, 2001
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhageR P Giugliano, C H McCabe, E M Antman, et al.Chronobiology International|November 8, 2012
Circadian variation in patient characteristics and outcomes in ST-segment elevation myocardial infarctionOwen Mogabgab, Robert P Giugliano, Marc S Sabatine, et al.Journal of Thrombosis and Thrombolysis|April 20, 2006
Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials)Shaheeda Ahmed, Elliott M Antman, Sabina A Murphy, et al.Journal of Cardiovascular Pharmacology and Therapeutics|September 26, 2013
Circadian variation of stent thrombosis and the effect of more robust platelet inhibition: a post hoc analysis of the TRITON-TIMI 38 trialOwen Mogabgab, Stephen D Wiviott, Christopher P Cannon, et al.Journal of the American College of Cardiology|November 25, 2000
Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudyD A Morrow, E M Antman, M Tanasijevic, et al.International Journal of Cardiology|January 12, 2008
The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromesShaheeda Ahmed, Christopher P Cannon, Robert P Giugliano, et al.Pageof 1,290